Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Acute Ischemic Stroke Despite Anticoagulation
暂无分享,去创建一个
A. Singhal | M. Selim | S. Yaghi | S. Kapur | Elif Gökçal | Scott B. Silverman | O. Rotschild | S. Greenberg | A. Das | Avia Abramovitz Fouks | MD MSc M. Edip Gurol
[1] S. Connolly,et al. Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation. , 2023, European heart journal.
[2] M. Price,et al. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation. , 2022, Journal of the American College of Cardiology.
[3] C. Nolte,et al. Aetiology, secondary prevention strategies and outcomes of ischaemic stroke despite oral anticoagulant therapy in patients with atrial fibrillation , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.
[4] S. Yusuf,et al. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. , 2021, The New England journal of medicine.
[5] Eric E. Smith,et al. Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study , 2021, Journal of Neurology, Neurosurgery, and Psychiatry.
[6] S. Verheye,et al. Left atrial appendage occlusion in recurrent ischaemic stroke, a multicentre experience , 2020, Acta clinica Belgica.
[7] N. Suzuki,et al. Atrial Fibrillation-Associated Ischemic Stroke Patients With Prior Anticoagulation Have Higher Risk for Recurrent Stroke , 2020, Stroke.
[8] D. Werring,et al. Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation , 2020, Annals of neurology.
[9] E. Heist,et al. A comparison of postprocedural anticoagulation in high‐risk patients undergoing WATCHMAN device implantation , 2019, Pacing and clinical electrophysiology : PACE.
[10] C. Ayata,et al. Pathophysiology of Lacunar Stroke: History's Mysteries and Modern Interpretations. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[11] M. Gurol,et al. Treatment Approaches to Lacunar Stroke. , 2019, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
[12] A. Regueiro,et al. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence. , 2019, The Journal of invasive cardiology.
[13] J. Zamorano,et al. Oral anticoagulation and left atrial appendage closure: a new strategy for recurrent cardioembolic stroke , 2019, European journal of neurology.
[14] Sung-Chun Tang,et al. Microangiopathy underlying mixed-location intracerebral hemorrhages/microbleeds , 2019, Neurology.
[15] K. Kario,et al. Prior Anticoagulation and Short‐ or Long‐Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial Fibrillation , 2019, Journal of the American Heart Association.
[16] M. Fisher,et al. Atrial Fibrillation for the Neurologist: Preventing both Ischemic and Hemorrhagic Strokes , 2018, Current Neurology and Neuroscience Reports.
[17] E. Antman,et al. Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.
[18] D. Atar,et al. Mass screening for silent atrial fibrillation in high risk patients - preliminary results from the STROKESTOP trial , 2013 .
[19] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[20] U. Mellqvist,et al. Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. , 2009, Blood.
[21] Lippincott Williams Wilkins,et al. Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.
[22] M. Gurol. Nonpharmacological Management of Atrial Fibrillation in Patients at High Intracranial Hemorrhage Risk , 2018, Stroke.
[23] R. Troughton,et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.